Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program’s benefits.
Providers push back on 340B rebate model
Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program’s benefits.
New York City-based NYU Langone Health recorded an operating income of $107.1 million (2.6% operating margin) in the second quarter of 2026, up from an operating …
Dr Aziza explains why napping could be a sign of a bigger issue
Iran issued a threat over the Strait of Hormuz after President Trump announced Sunday that the U.S. would assist in freeing up vessels in the vital …
دراسة منشورة في لانست تكشف أن أجهزة المراقبة المستمرة للجلوكوز تحسن مستويات السكر لدى مرضى السكري النوع الثاني